1. Home
  2. GAUZ vs ATYR Comparison

GAUZ vs ATYR Comparison

Compare GAUZ & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • ATYR
  • Stock Information
  • Founded
  • GAUZ 2009
  • ATYR 2005
  • Country
  • GAUZ Israel
  • ATYR United States
  • Employees
  • GAUZ N/A
  • ATYR N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GAUZ Miscellaneous
  • ATYR Health Care
  • Exchange
  • GAUZ Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • GAUZ 193.8M
  • ATYR 228.1M
  • IPO Year
  • GAUZ 2024
  • ATYR 2015
  • Fundamental
  • Price
  • GAUZ $11.51
  • ATYR $3.63
  • Analyst Decision
  • GAUZ Strong Buy
  • ATYR Strong Buy
  • Analyst Count
  • GAUZ 4
  • ATYR 5
  • Target Price
  • GAUZ $16.25
  • ATYR $19.25
  • AVG Volume (30 Days)
  • GAUZ 71.5K
  • ATYR 960.8K
  • Earning Date
  • GAUZ 02-10-2025
  • ATYR 03-13-2025
  • Dividend Yield
  • GAUZ N/A
  • ATYR N/A
  • EPS Growth
  • GAUZ N/A
  • ATYR N/A
  • EPS
  • GAUZ N/A
  • ATYR N/A
  • Revenue
  • GAUZ $94,346,000.00
  • ATYR $235,000.00
  • Revenue This Year
  • GAUZ $34.69
  • ATYR N/A
  • Revenue Next Year
  • GAUZ $35.73
  • ATYR $1,080.92
  • P/E Ratio
  • GAUZ N/A
  • ATYR N/A
  • Revenue Growth
  • GAUZ 29.76
  • ATYR N/A
  • 52 Week Low
  • GAUZ $6.78
  • ATYR $1.42
  • 52 Week High
  • GAUZ $17.10
  • ATYR $4.23
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ N/A
  • ATYR 53.70
  • Support Level
  • GAUZ N/A
  • ATYR $3.17
  • Resistance Level
  • GAUZ N/A
  • ATYR $3.83
  • Average True Range (ATR)
  • GAUZ 0.00
  • ATYR 0.25
  • MACD
  • GAUZ 0.00
  • ATYR -0.02
  • Stochastic Oscillator
  • GAUZ 0.00
  • ATYR 43.60

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a integrated light and vision control company, Its products include suspended particle device, or SPD, and liquid crystal, or LC, films for smart glass applications, as well as camera monitoring systems, or CMS, and other advanced driver assistance systems, or ADAS, solutions. It has three operating segments. Architecture and automotive segment focuses on sales that enable OEMs to incorporate the Company's technology in glass rooftops, side windows and windshields. Safety tech segment focuses on sales of advanced driver assistance systems for buses, coaches, recreational vehicles and specific vehicles. Aeronautics segment focuses on the sale of shading and cabin management systems in private and commercial aircraft and helicopters. Key revenue is generated from Aeronauctis.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: